The Joint Corp. (NASDAQ:JYNT – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 528,100 shares, an increase of 9.2% from the September 30th total of 483,800 shares. Based on an average trading volume of 49,100 shares, the days-to-cover ratio is currently 10.8 days.
Joint Stock Down 1.2 %
NASDAQ:JYNT traded down $0.14 on Wednesday, reaching $11.20. The stock had a trading volume of 17,759 shares, compared to its average volume of 68,873. The company has a market capitalization of $167.71 million, a P/E ratio of -15.12 and a beta of 1.57. Joint has a 1-year low of $7.31 and a 1-year high of $17.82. The stock has a fifty day moving average price of $11.24 and a 200-day moving average price of $13.01.
Joint (NASDAQ:JYNT – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Joint had a negative net margin of 12.00% and a positive return on equity of 2.17%. The firm had revenue of $30.26 million during the quarter, compared to analyst estimates of $29.65 million. Sell-side analysts predict that Joint will post 0.13 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Joint
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Read More
- Five stocks we like better than Joint
- What is a Dividend King?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Find and Profitably Trade Stocks at 52-Week Lows
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.